Alto Neuroscience (ANRO) Stock: Buy, Sell, or Hold?
ANRO - Alto Neuroscience Inc.
$23.32
-1.09 (-4.47%)
▼
5d:
+7.42%
30d:
-24.24%
90d:
-13.15%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 11, 2026
19d
Get Alerted When ANRO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ANRO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: ANRO shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: ANRO is currently trading at $23.32, which is considered slightly low relative to its 30-day fair value range of $22.89 to $29.07.
Technical Outlook: Technically, ANRO is in a uptrend. Immediate support is located at $21.32, while resistance sits at $25.25. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: ANRO scores 95/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.88 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANRO is in a uptrend. Immediate support is located at $21.32, while resistance sits at $25.25. Short-term momentum is weak, with the stock down 4.5% recently.
Market Sentiment: ANRO scores 95/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $38.88 (+66.7%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$22.89 -
$29.07
Company Quality Score
71/100
(BUY)
Options IV Signal
44th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
85.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 44th percentile)
- BULLISH: Strong technical setup (95/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.5%)
- BULLISH: Trading 66.7% below Wall St target ($38.88)
- BULLISH: Bottoming setup score 95/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$22.89 -
$29.07
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$3.57
(15.3%)
Support & Resistance Levels
Support Level
$21.32
Resistance Level
$25.25
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-11.69
Wall Street Target
$38.88
(+66.7%)
Share & Embed Analysis
Last updated: October 22, 2026 7:41 AM ET
Data refreshes hourly during market hours. Next update: 8:41 AM
Data refreshes hourly during market hours. Next update: 8:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANRO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 60 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 66 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 59 HOLD |
|
CGON
CG Oncology, Inc. Common… |
STRONG BUY
15 analysts |
$91 | 73 BUY |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 63 BUY |
